Quick Answer
BIO-RAD LABORATORIES, INC. reported Cash and Equivalents of $529.80 million for fiscal year 2025.
BIO-RAD LABORATORIES, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $529.80M | +8.5% |
| 2024 | $488.10M | +20.9% |
| 2023 | $403.80M | -7.0% |
| 2022 | $434.20M | -7.8% |
| 2021 | $470.78M | -28.9% |
| 2020 | $662.21M | +0.2% |
| 2019 | $660.67M | +53.1% |
| 2018 | $431.53M | +12.4% |
| 2017 | $383.82M | -15.9% |
| 2016 | $456.26M | -0.3% |
| 2015 | $457.55M | +10.7% |
| 2014 | $413.25M | +24.6% |
| 2013 | $331.55M | -28.5% |
| 2012 | $463.39M | -19.3% |
| 2011 | $574.23M | -36.7% |
| 2010 | $906.55M | +39.5% |
| 2009 | $649.94M | +217.8% |
| 2008 | $204.52M | +26.4% |
| 2007 | $161.76M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $395.80M | -3.6% | +7.2% |
| June 30, 2025 | $369.30M | -9.2% | -29.2% |
| March 31, 2025 | $521.40M | +20.3% | +6.8% |
| December 31, 2024 | $488.10M | +20.9% | +18.9% |
| September 30, 2024 | $410.40M | -10.4% | +0.9% |
| June 30, 2024 | $406.90M | +4.3% | -6.1% |
| March 31, 2024 | $433.30M | -6.6% | +7.3% |
| December 31, 2023 | $403.81M | -7.0% | -11.8% |
- BIO-RAD LABORATORIES, INC. showed an increase of +8.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2007–2025 period, BIO-RAD LABORATORIES, INC.’s cash and equivalents has grown by 227.5% (from $161.76 million to $529.80 million).
- The most recent figure is from BIO-RAD LABORATORIES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: